查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574942

药物製剂市场，按剂型、适应症、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Drug Formulation Market, By Dosage Form, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年药物製剂市场规模为1,759,023.43百万美元，2024年至2032年复合年增长率为6.01%。

药物製剂市场-市场动态

对个人化医疗和标靶治疗的需求不断增长推动成长

对个人化医疗和标靶治疗的需求不断增长正在推动药物製剂市场的成长。个人化医疗根据患者的个别需求客製化治疗方案，提高治疗效果和效率。根据美国国立卫生研究院 (NIH) 的数据，超过 1,800 项活跃的临床试验正在关注个人化治疗。

这一转变凸显了为不同患者群体制定量身定制治疗方案的重要性。教育机构也透过研究新配方和治疗策略做出贡献。随着医疗保健的发展，对个人化方法的重视可能会扩大，这将使患者和药物製剂产业受益。

药物製剂市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 6.01% 左右的复合年增长率成长

根据剂型细分，预计口服製剂将在 2023 年显示最大的市场份额

依适应症细分，2023年传染病为主导类型

根据最终用户细分，大型製药公司是 2023 年的领先类型

按地区划分，北美是 2023 年的主要收入来源

药物製剂市场-細項分析：

全球药物製剂市场根据剂型、适应症、最终用户和地区进行细分。

依剂型，市场分为三类：口服製剂、肠胃外製剂、外用製剂及吸入製剂。口服製剂是最突出的部分。此类别包括片剂和胶囊等各种形式，由于其方便和易于服用而被广泛使用。其中，片剂，尤其是速释片剂，因其生产简单且保质期长而广受欢迎。口服製剂因其有效性和舒适性而受到患者和医疗保健提供者的青睐，使其成为市场上的主导选择。

根据适应症，市场分为两类：传染病、癌症、心血管疾病、糖尿病、呼吸系统疾病、中枢神经系统疾病等。传染病是最突出的部分。这主要是由于对有效治疗和疫苗的持续需求，特别是最近的全球健康危机（如 COVID-19 大流行）。由于医疗保健系统专注于预防和治疗感染，对抗病毒和抗生素药物的需求仍然很高。此外，该领域新疗法的快速发展推动了创新和投资，使传染病成为药物配方的主要焦点。

药物製剂市场-地理洞察

北美药物製剂市场非常重要且成长迅速。美国是该市场最大的部分，许多製药公司都在开发新药。这些公司专注于创造安全有效的药物配方来治疗各种健康问题。技术和研究的进步正在帮助改进药​​物输送方法。加拿大也透过支持医疗保健领域的研究和创新做出贡献。此外，严格的法规确保了药物配方的高品质标准。总体而言，北美在塑造药物製剂市场的未来方面发挥着至关重要的作用。

药物製剂市场-竞争格局：

药物製剂市场竞争激烈，辉瑞、强生和罗氏等主要参与者处于领先地位。这些公司大力投资研发，以创造新的有效药物。默克公司和百时美施贵宝也是重要的竞争对手，专注于创新疗法。葛兰素史克和诺华凭藉其强大的产品组合和全球影响力做出了贡献。此外，艾伯维（AbbVie）和安进（Amgen）等公司以其特种药物而闻名。在技​​术进步和不断变化的医疗保健需求的推动下，市场不断发展。这项竞赛促进创新，有助于为患者提供更好的治疗方法。

最新进展：

2024 年 9 月，赛诺菲、RadioMedix 和 Orano Med 宣布达成针对罕见癌症的下一代放射性配体治疗的许可协议。此次合作的重点是为患有这些特定病症的患者推进创新疗法。

20224 年 5 月，诺华同意收购 Mariana Oncology，扩大放射配体治疗产品线。这项策略性措施增强了诺华开发标靶癌症治疗的能力。

目录

第 1 章：药物製剂市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按剂型分類的药物製剂市场片段
    • 以适应症分類的药物製剂市场片段
    • 最终使用者的药物製剂市场片段
    • 按国家/地区分類的药物製剂市场摘要
    • 按地区分類的药物製剂市场片段
  • 竞争洞察

第 3 章：药物製剂主要市场趋势

  • 药物製剂市场驱动因素
    • 市场驱动因素的影响分析
  • 药物製剂市场限制
    • 市场限制影响分析
  • 药物製剂市场机会
  • 药物製剂市场未来趋势

第 4 章：药物製剂产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：药物製剂市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：药物製剂市场格局

  • 2023 年药物製剂市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：药物製剂市场 - 按剂型

  • 概述
    • 按剂型分類的细分市场占有率分析
    • 口服製剂
      • 平板电脑
      • 立即发布
      • 修改版本
      • 咀嚼片
      • 泡腾片
      • 胶囊
      • 硬明胶胶囊
      • 软胶囊
      • 其他的
      • 粉末和颗粒
      • 锭剂和锭剂
      • 软糖
      • 其他的
    • 肠胃外製剂
      • 解决方案
      • 暂停
      • 注射或输注用乳剂
      • 注射或输注用粉剂
      • 用于注射植入物的凝胶
    • 外用製剂
      • 膏体
      • 药膏和油
      • 霜剂、乳液和泡沫。
      • 凝胶剂、酊剂和粉末
      • 喷雾剂和贴剂
    • 吸入製剂
      • 加压定量吸入器
      • 干粉吸入器 (DPI)
      • 喷雾器

第 8 章：药物製剂市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 传染病
    • 癌症
    • 心血管疾病
    • 糖尿病
    • 呼吸系统疾病
    • 中枢神经系统疾病
    • 其他的

第 9 章：药物製剂市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 大型製药公司
    • 中小型製药公司
    • 生技公司

第 10 章：药物製剂市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美药物製剂主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按剂型）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲药物製剂主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按剂型）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区药物製剂主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按剂型）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲药物製剂主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按剂型）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲药物製剂主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按剂型）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 药物製剂产业

  • 竞争仪表板
  • 公司简介
    • Pfizer
    • Johnson & Johnson
    • Roche
    • Merck & Co.
    • Bristol-Myers Squibb
    • GSK (GlaxoSmithKline)
    • Novartis
    • AbbVie
    • Sanofi
    • Amgen
    • AstraZeneca
    • Bayer
    • Teva Pharmaceutical Industries
    • Mylan
    • Celgene

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3941

REPORT HIGHLIGHT

Drug Formulation Market size was valued at USD 1,759,023.43 Million in 2023, expanding at a CAGR of 6.01% from 2024 to 2032.

The drug formulation market involves the development and production of medications in various forms, like tablets, capsules, and injections. It focuses on combining active ingredients with other substances to create effective and safe drugs. This market plays a crucial role in healthcare by ensuring that medicines can deliver the right dosage and work effectively in the body. Companies in this market conduct research to improve existing drugs and develop new ones. The goal is to provide better treatments for various diseases and conditions. Overall, the drug formulation market is essential for advancing medicine and improving patient care.

Drug Formulation Market- Market Dynamics

Rising demand for personalized medicine and targeted therapies drives growth

Rising demand for personalized medicine and targeted therapies is driving growth in the drug formulation market. Personalized medicine tailors' treatments to individual patient needs, improving outcomes and efficiency. According to the National Institutes of Health (NIH), over 1,800 active clinical trials are focusing on personalized therapies.

This shift highlights the importance of creating tailored treatments for various patient groups. Educational institutions also contribute by researching new formulations and treatment strategies. As healthcare evolves, the emphasis on personalized approaches is likely to expand, benefiting both patients and the drug formulation industry.

Drug Formulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2024-2032)

Based on Dosage Form segmentation, Oral formulations was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Infectious Diseases was the leading type in 2023

Based on End User segmentation, Big Pharma Companies was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Drug Formulation Market- Segmentation Analysis:

The Global Drug Formulation Market is segmented based on Dosage Form, Indication, End User, and Region.

The market is divided into three categories based on Dosage Form: Oral formulations, Parenteral formulations, Topical formulations, and Inhalation formulations. Oral formulations are the most prominent segment. This category includes various forms like tablets and capsules, which are widely used due to their convenience and ease of administration. Among these, tablets, especially immediate-release ones, are highly popular because they are simple to produce and have a long shelf life. Oral formulations are preferred by both patients and healthcare providers for their effectiveness and comfort, making them the dominant choice in the market.

The market is divided into two categories based on Indication: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, and Others. Infectious diseases represent the most prominent segment. This is largely due to the ongoing need for effective treatments and vaccines, especially highlighted by recent global health crises like the COVID-19 pandemic. The demand for antiviral and antibiotic drugs remains high as healthcare systems focus on preventing and treating infections. Additionally, the rapid development of new therapies in this area drives innovation and investment, making infectious diseases a dominant focus in drug formulation.

Drug Formulation Market- Geographical Insights

The North American drug formulation market is very important and is growing quickly. The United States is the largest part of this market, with many pharmaceutical companies developing new medicines. These companies focus on creating safe and effective drug formulations to treat various health issues. Advances in technology and research are helping improve drug delivery methods. Canada is also contributing by supporting research and innovation in the healthcare sector. Additionally, strict regulations ensure high-quality standards for drug formulations. Overall, North America plays a crucial role in shaping the future of the drug formulation market.

Drug Formulation Market- Competitive Landscape:

The drug formulation market is competitive, with major players like Pfizer, Johnson & Johnson, and Roche leading the way. These companies invest heavily in research and development to create new and effective medications. Merck & Co. and Bristol-Myers Squibb are also significant competitors, focusing on innovative therapies. GSK and Novartis contribute with their strong product portfolios and global reach. Additionally, companies like AbbVie and Amgen are known for their specialty drugs. The market is constantly evolving, driven by advancements in technology and changing healthcare needs. This competition fosters innovation and helps bring better treatments to patients.

Recent Developments:

In September 2024, Sanofi, RadioMedix, and Orano Med announced a licensing agreement for a next-generation radioligand treatment aimed at rare cancers. This collaboration focuses on advancing innovative therapies for patients with these specific conditions.

In May 20224 Novartis has agreed to acquire Mariana Oncology, boosting its radioligand therapy pipeline. This strategic move enhances Novartis's capabilities in developing targeted cancer treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG FORMULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer
  • Johnson & Johnson
  • Roche
  • Merck & Co.
  • Bristol-Myers Squibb
  • GSK (GlaxoSmithKline)
  • Novartis
  • AbbVie
  • Sanofi
  • Amgen
  • AstraZeneca
  • Bayer
  • Teva Pharmaceutical Industries
  • Mylan
  • Celgene

GLOBAL DRUG FORMULATION MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Oral formulations
  • Tablets
  • Immediate Release
  • Modified Release
  • Chewable
  • Effervescent
  • Capsules
  • Hard Gelatine Capsules
  • Soft gel Capsules
  • Others
  • Powders & Granules
  • Lozenges & Pastilles
  • Gummies
  • Others
  • Parenteral formulations
  • Solutions
  • Suspensions
  • Emulsions for injection or infusion
  • Powders for injection or infusion
  • Gels for injection implants
  • Topical formulations
  • Pastes
  • Ointments and oils
  • Creams, lotions, and foams.
  • Gels, tinctures, and powders
  • Sprays and patches
  • Inhalation formulations
  • Pressurized Metered Dose Inhaler
  • Dry Powder Inhaler (DPI)
  • Nebulizer

GLOBAL DRUG FORMULATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Others

GLOBAL DRUG FORMULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Big Pharma Companies
  • Small & Medium Size Pharma Companies
  • Biotech Companies

GLOBAL DRUG FORMULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Formulation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Formulation Market Snippet by Dosage Form
    • 2.1.2. Drug Formulation Market Snippet by Indication
    • 2.1.3. Drug Formulation Market Snippet by End User
    • 2.1.4. Drug Formulation Market Snippet by Country
    • 2.1.5. Drug Formulation Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Formulation Key Market Trends

  • 3.1. Drug Formulation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Formulation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Formulation Market Opportunities
  • 3.4. Drug Formulation Market Future Trends

4. Drug Formulation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Formulation Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Drug Formulation Market Landscape

  • 6.1. Drug Formulation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Formulation Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Oral formulations
      • 7.1.2.1. Tablets
      • 7.1.2.1.1. Immediate Release
      • 7.1.2.1.2. Modified Release
      • 7.1.2.1.3. Chewable
      • 7.1.2.1.4. Effervescent
      • 7.1.2.2. Capsules
      • 7.1.2.2.1. Hard Gelatine Capsules
      • 7.1.2.2.2. Soft gel Capsules
      • 7.1.2.2.3. Others
      • 7.1.2.3. Powders & Granules
      • 7.1.2.4. Lozenges & Pastilles
      • 7.1.2.5. Gummies
      • 7.1.2.6. Others
    • 7.1.3. Parenteral formulations
      • 7.1.3.1. Solutions
      • 7.1.3.2. Suspensions
      • 7.1.3.3. Emulsions for injection or infusion
      • 7.1.3.4. Powders for injection or infusion
      • 7.1.3.5. Gels for injection implants
    • 7.1.4. Topical formulations
      • 7.1.4.1. Pastes
      • 7.1.4.2. Ointments and oils
      • 7.1.4.3. Creams, lotions, and foams.
      • 7.1.4.4. Gels, tinctures, and powders
      • 7.1.4.5. Sprays and patches
    • 7.1.5. Inhalation formulations
      • 7.1.5.1. Pressurized Metered Dose Inhaler
      • 7.1.5.2. Dry Powder Inhaler (DPI)
      • 7.1.5.3. Nebulizer

8. Drug Formulation Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Cancer
    • 8.1.4. Cardiovascular Diseases
    • 8.1.5. Diabetes
    • 8.1.6. Respiratory Diseases
    • 8.1.7. Central Nervous System Disorders
    • 8.1.8. Others

9. Drug Formulation Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Big Pharma Companies
    • 9.1.3. Small & Medium Size Pharma Companies
    • 9.1.4. Biotech Companies

10. Drug Formulation Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Drug Formulation Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Drug Formulation Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Drug Formulation Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Drug Formulation Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Drug Formulation Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Drug Formulation Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer
    • 11.2.2. Johnson & Johnson
    • 11.2.3. Roche
    • 11.2.4. Merck & Co.
    • 11.2.5. Bristol-Myers Squibb
    • 11.2.6. GSK (GlaxoSmithKline)
    • 11.2.7. Novartis
    • 11.2.8. AbbVie
    • 11.2.9. Sanofi
    • 11.2.10. Amgen
    • 11.2.11. AstraZeneca
    • 11.2.12. Bayer
    • 11.2.13. Teva Pharmaceutical Industries
    • 11.2.14. Mylan
    • 11.2.15. Celgene

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us